The developments at Holland Capital in 2024 reflect our strong ambitions
Amsterdam/ Düsseldorf, 30th of December 2024 –The developments at Holland Capital in 2024 reflect our strong ambitions. Guided by a focused investment strategy, we continued to actively engage in the high-growth markets of Technology, Healthcare, and Agrifood. Reflecting on a successful year, we completed several key transactions and further strengthened our team.
2024 achievements
- The launch of our fund, Holland Capital Growth and Buy-Out Fund V
- Number of deals in the Netherlands: 5
- Number of add-on acquisitions in the Netherlands: 13
- Number of add-on acquisitions in Germany: 2
- Number of exits: 2
- Number of new colleagues: 4
Sector focus and an entrepreneurial hands-on approach: With specialized sector teams, we focus on the sectors of Healthcare, Technology, and Agrifood, both within the Growth & Buy-out and Venture & Growth segments. We understand the dynamics and opportunities in these sectors and have an extensive network. Holland Capital is not a passive investor; we work closely with management to define and execute strategies. Where needed, our operational team also contributes hands-on to the realization of specific projects within the company.
Which companies would we like to connect with?
- Sector: Technology, Healthcare, and Agrifood
- Positive outlook: Significant growth potential, both autonomous and buy-and-build
- Growth & Buy-out:
- Healthy profitability: cash flow from operations (EBITDA) between EUR 1 – 10m
- Smaller companies: considered as add-on acquisitions for our existing portfolio companies
- Larger companies: considered together with a co-investor
- Venture & Growth:
- Start-ups and scale-ups: EBITDA EUR <1m
- Cash flow negative (in an accelerated growth scenario)
- Revenue EUR 0 – 5m
What to expect from us?
- Flexible approach to transaction structures: We strive to adapt each structure to the needs of the company and its shareholders. Depending on the type of investment, Holland Capital either provides growth capital and/or acquires existing shares. We are flexible regarding the final capital structure: both majority and minority stakes are possible.
- Deal certainty and an efficient process: Thanks to our sector expertise, we are able to quickly assess a business model and put a fair price on the table. Since the partnership with the entrepreneur and/or the management team is the cornerstone of our investment, we devote above-average attention to ensuring the process is completed efficiently, in the right spirit, and with mutual respect for both parties.
- Transparency towards advisors: We appreciate it when advisors involve us early in discussions with entrepreneurs and/or management teams. In such cases, we always ensure that the advisor’s interests are well safeguarded throughout the process. The advisor retains the flexibility to decide whether to represent the sell-side or buy-side in a potential transaction.
About Holland Capital
Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and fosters an open, sustainable, and professional relationship with the management teams of the invested companies, aiming for mutual growth. With offices in Amsterdam and Düsseldorf, Holland Capital focuses on Healthcare, Technology, and Agrifood-Tech sector.
Magnus accelerates growth through collaboration with Holland Capital
Magnus accelerates growth through collaboration with Holland Capital Amsterdam / Naarden, November 26, 2020 - Holland Capital invests in consultancy company Magnus, a major player in the field of digital transformation. With its broad IT expertise, Magnus is a...
Holland Capital investeert in innovatieve dienstverlener in logistiek en identificatie AMP Groep
Holland Capital investeert in innovatieve dienstverlener in logistiek en identificatie AMP Groep Amsterdam/Houten, 6 oktober 2020 – Participatiemaatschappij Holland Capital investeert in AMP Groep, een innovatieve dienstverlener in logistiek en identificatie. De...
Holland Capital invests in AMP Groep, an innovative service provider in logistics and identification
Holland Capital invests in AMP Groep, an innovative service provider in logistics and identification Amsterdam / Houten, October 6th, 2020 – Investment firm Holland Capital invests in AMP Groep, an innovative service provider active in the logistics and identification...
U-Needle secures growth financing for the global rollout of its Bella-mu product range
Amsterdam/Enschede, 1st of October 2020 – Holland Capital invests in U-Needle with Waterman Ventures and along with existing shareholders including UT International Ventures incubator fund. U-Needle has developed Bella-mu, a range of needles created for intradermal...
U-Needle trekt groeikapitaal aan voor de wereldwijde uitrol van de Bella-mu
Amsterdam/Enschede, 1 oktober 2020 – Holland Capital investeert samen met Waterman Ventures en bestaande aandeelhouders, waaronder het UT International Ventures incubator fonds, in U-Needle. U-Needle heeft de Bella-mu ontwikkeld, een productlijn van naalden voor de...
Yenlo en Fides bundelen krachten
Amsterdam, 21 september 2020 – Onze deelneming Yenlo (de integratiespecialist op het gebied van API- en ESB-technologie) en Fides (de AFAS migratie- en integratiepartner voor zorg en onderwijs) bundelen hun krachten. Door deze samenwerking kunnen ze de integratie voor...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl